Moderna says US government on the hook to pay any royalties due to mRNA patent owners
The company claims any infringing uses of its vaccine are insulated from liability under compulsory licensing law
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.